Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Benpen
2. Benzylpenicillin
3. Benzylpenicillin Potassium
4. Coliriocilina
5. Crystapen
6. Or-pen
7. Parcillin
8. Pekamin
9. Pengesod
10. Penibiot
11. Penicilina G Llorente
12. Penicillin G Jenapharm
13. Penicillin G Potassium
14. Penicillin G Sodium
15. Penicillin Grnenthal
16. Penilevel
17. Peniroger
18. Pfizerpen
19. Sodiopen
20. Sodipen
21. Sodium Benzylpenicillin
22. Sodium Penicillin
23. Unicilina
24. Ursopen
25. Van-pen-g
1. Benzylpenicillin
2. 61-33-6
3. Benzylpenicillinic Acid
4. Benzyl Penicillin
5. Free Penicillin Ii
6. Pfizerpen
7. Bencilpenicilina
8. Benzylpenicillinum
9. Benzylpenicilline
10. Benzylpenicillin G
11. 6-(2-phenylacetamido)penicillanic Acid
12. Free Penicillin G
13. Benzopenicillin
14. Dropcillin
15. Gelacillin
16. Liquacillin
17. Pharmacillin
18. Cilopen
19. Pradupen
20. Specilline G
21. (5r,6r)-benzylpenicillin
22. Penicillin, (phenylmethyl)-
23. Galofak
24. Free Benzylpenicillin
25. Penicillin-g Potassium
26. Compocillin G
27. Bensylpenicillin
28. Benzyl Benicillin
29. Penicillinic Acid, (phenylmethyl)-
30. Phenylacetamidopenicillanic Acid
31. (2s,5r,6r)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
32. Pencillin G
33. Cilloral
34. Cosmopen
35. Chebi:18208
36. J01ce01
37. Benzyl-6-aminopenicillinic Acid
38. Penicillinic Acid, Benzyl-
39. (phenylmethyl)penicillin
40. Q42t66vg0c
41. Ursopen
42. (phenylmethyl)penicillinic Acid
43. Nsc-193396
44. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)- (2s-(2alpha,5alpha,6beta))-
45. Benzylpenicillin (inn)
46. (2s,5r,6r)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid
47. (2s,5r,6r)-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
48. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-
49. Benzylpenicillin [inn]
50. Cillora
51. Penicilling
52. Bencilpenicilina [spanish]
53. Benzylpenicilline [french]
54. Benzylpenicillinum [latin]
55. Benzylpenicillin [inn:ban]
56. 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- [2s-(2alpha,5alpha,6beta)]-
57. Smr000538912
58. Hsdb 3166
59. Einecs 200-506-3
60. Nsc 193396
61. Brn 0044740
62. Unii-q42t66vg0c
63. Penicillin,(s)
64. 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-
65. Penicillin-g
66. Spectrum_000933
67. Chembl29
68. Prestwick0_001078
69. Prestwick1_001078
70. Prestwick2_001078
71. Prestwick3_001078
72. Spectrum2_000518
73. Spectrum3_000542
74. Spectrum4_000471
75. Spectrum5_001108
76. Epitope Id:114070
77. Penicillin G [mi]
78. Schembl3783
79. Penicillin G [hsdb]
80. Bspbio_001096
81. Bspbio_002183
82. Kbiogr_000942
83. Kbioss_001413
84. Penicillin G [vandf]
85. (2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
86. 4-27-00-05861 (beilstein Handbook Reference)
87. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-, (2s-(2alpha,5alpha,6beta))-
88. Mls000766897
89. Mls001032123
90. Mls001173382
91. Divk1c_000316
92. Spbio_000475
93. Spbio_002998
94. Bpbio1_001206
95. Gtpl4796
96. Benzylpenicillin [mart.]
97. Dtxsid5046934
98. Kbio1_000316
99. Kbio2_001413
100. Kbio2_003981
101. Kbio2_006549
102. Kbio3_001683
103. Benzylpenicillin [who-dd]
104. Ninds_000316
105. Glxc-25718
106. Hms2875l09
107. Hy-n7139
108. Zinc3871701
109. Bdbm50022787
110. Phenylacetyl-6-aminopenicillanic Acid
111. Akos005203091
112. Db01053
113. Idi1_000316
114. Ncgc00159348-02
115. Ncgc00159348-03
116. (2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid
117. 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 3,3-dimethyl-7-oxo-6- (2-phenylacetamido)-
118. 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- (2s,5r,6r)-
119. Sbi-0051476.p003
120. (2s,5r,6r)-3,3-dimethyl-7-oxo-6-
121. Bicillin (*benzathine Salt, Tetrahydrate*)
122. Cs-0013727
123. C05551
124. D02336
125. (2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]
126. 061p336
127. A833169
128. Q258450
129. W-109262
130. Brd-k55191674-236-03-7
131. Brd-k55191674-237-02-7
132. Brd-k55191674-237-12-6
133. Benzylpenicillin, Antibiotic For Culture Media Use Only
134. Phenoxymethylpenicillin Impurity A [ep Impurity]
135. 2,2-dimethyl-6beta-(phenylacetamido)penam-3alpha-carboxylic Acid
136. Phenoxymethylpenicillin Potassium Impurity A [ep Impurity]
137. (+)-3,3-dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic Acid(penicillin G)
138. (2s,5r,6r)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic Acid
139. (2s,5r,6r)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid
140. (2s,5r,6r)-3,3-dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic Acid
141. 3,3-dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic Acid
142. 3,3-dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic Acid Anion (penicillin G)
143. 3,3-dimethyl-7-oxo-6-phenylacetylamino-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic Acid(penicillin G)
144. 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2s,5r,6r)-
145. 4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-, (2s,5r,6r)-
| Molecular Weight | 334.4 g/mol |
|---|---|
| Molecular Formula | C16H18N2O4S |
| XLogP3 | 1.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 4 |
| Exact Mass | 334.09872823 g/mol |
| Monoisotopic Mass | 334.09872823 g/mol |
| Topological Polar Surface Area | 112 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 530 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 4 | |
|---|---|
| Drug Name | Penicillin g potassium in plastic container |
| Drug Label | Buffered Pfizerpen (penicillin G potassium) for Injection is a sterile, pyrogen-free powder for reconstitution. Buffered Pfizerpen for Injection is an antibacterial agent for intramuscular, continuous intravenous drip, intrapleural or other local inf... |
| Active Ingredient | Penicillin g potassium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 20,000 units/ml; 40,000 units/ml; 60,000 units/ml |
| Market Status | Prescription |
| Company | Baxter Hlthcare |
| 2 of 4 | |
|---|---|
| Drug Name | Pfizerpen |
| Active Ingredient | Penicillin g potassium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 20,000,000 units/vial; 5,000,000 units/vial |
| Market Status | Prescription |
| Company | Pfizer |
| 3 of 4 | |
|---|---|
| Drug Name | Penicillin g potassium in plastic container |
| Drug Label | Buffered Pfizerpen (penicillin G potassium) for Injection is a sterile, pyrogen-free powder for reconstitution. Buffered Pfizerpen for Injection is an antibacterial agent for intramuscular, continuous intravenous drip, intrapleural or other local inf... |
| Active Ingredient | Penicillin g potassium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 20,000 units/ml; 40,000 units/ml; 60,000 units/ml |
| Market Status | Prescription |
| Company | Baxter Hlthcare |
| 4 of 4 | |
|---|---|
| Drug Name | Pfizerpen |
| Active Ingredient | Penicillin g potassium |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | 20,000,000 units/vial; 5,000,000 units/vial |
| Market Status | Prescription |
| Company | Pfizer |
Convulsants; GABA Modulators; Penicillins
National Library of Medicine's Medical Subject Headings online file (MeSH, 1999)
GINGIVOSTOMATITIS, PULMONARY INFECTIONS, & GENITAL DISEASE PRODUCED BY SYNERGISTIC ACTION OF FUSOBACTERIUM NUCLEATUM (FUSIFORM) & SPIROCHETES PRESENT IN RESPIRATORY TRACT ARE READILY TREATABLE WITH PENICILLIN. /PENICILLIN/
Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1074
TWO MICROORGANISMS RESPONSIBLE FOR.../RAT-BITE FEVER/ ARE SENSITIVE TO PENICILLIN G. ...DRUG OF CHOICE IN MGMNT OF INFECTIONS DUE TO LIST MONOCYTOGENES... ONLY SPECIES OF PASTEURELLA HIGHLY SUSCEPTIBLE TO PENICILLIN IS PAST MULTOCIDA. ... CAUSATIVE AGENT OF /ERYSIPELOID/...IS SENSITIVE TO PENICILLIN.
Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1074
PENICILLIN G THERAPY OF SYPHILIS IS ALMOST IDEALLY SAFE, INEXPENSIVE, & HIGHLY EFFECTIVE. ...AGENT OF CHOICE FOR TREATMENT OF ALL CLINICAL FORMS OF ACTINOMYCOSIS...ANTHRAX...GAS GANGRENE...
Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1073
For more Therapeutic Uses (Complete) data for PENICILLIN G (35 total), please visit the HSDB record page.
WHEN MASSIVE DOSES OF PENICILLIN G SODIUM ARE USED, CONSIDERABLE SODIUM LOAD IS INTRODUCED, WHICH EXPANDS EXTRACELLULAR SPACE & MAY CAUSE EDEMA IN PT WITH HEART FAILURE. /PENICILLIN G SODIUM/
Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 1132
ALLERGIES CAN OCCUR TO PROCAINE COMPONENT, BUT OTHER TOXIC EFFECTS OF PROCAINE ARE VERY RARE. /PROCAINE/
Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 1132
ANURIA INCR HALF-LIFE OF PENICILLIN G FROM NORMAL VALUE OF 1/2 HR TO ABOUT 10 HR.
Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1071
ALTHOUGH PENICILLIN G PREPN FOR INHALATION THERAPY & FOR TOPICAL APPLICATION TO SKIN & MUCOUS MEMBRANES ARE STILL AVAIL, THEIR USE IS NOT RECOMMENDED BECAUSE PROOF THAT THEY ARE ADEQUATELY EFFECTIVE IS LACKING, & BECAUSE THEY PRODUCE HIGH INCIDENCE OF HYPERSENSITIZATION.
Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1071
For more Drug Warnings (Complete) data for PENICILLIN G (23 total), please visit the HSDB record page.
For use in the treatment of severe infections caused by penicillin G-susceptible microorganisms when rapid and high penicillin levels are required such as in the treatment of septicemia, meningitis, pericarditis, endocarditis and severe pneumonia.
Penicillin G is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name "penicillin" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. Penicillin G has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of penicillin G results from the inhibition of cell wall synthesis and is mediated through penicillin G binding to penicillin binding proteins (PBPs). Penicillin G is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases.
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01C - Beta-lactam antibacterials, penicillins
J01CE - Beta-lactamase sensitive penicillins
J01CE01 - Benzylpenicillin
S - Sensory organs
S01 - Ophthalmologicals
S01A - Antiinfectives
S01AA - Antibiotics
S01AA14 - Benzylpenicillin
Absorption
Rapidly absorbed following both intramuscular and subcutaneous injection. Initial blood levels following parenteral administration are high but transient. Oral absorption in fasting, healthy humans is only about 15-30% as it is very susceptible to acid-catalyzed hydrolysis.
Route of Elimination
Penicillin G is eliminated by the kidneys. Nonrenal clearance includes hepatic metabolism and, to a lesser extent, biliary excretion.
Volume of Distribution
0.530.67 L/kg in adults with normal renal function
Clearance
560ml/min in healthy humans
...WIDELY DISTRIBUTED THROUGHOUT BODY... ITS APPARENT VOL OF DISTRIBUTION IS IN ABOUT 50% OF TOTAL BODY WATER. MORE THAN 90%...IN BLOOD IS IN PLASMA & LESS THAN 10% IS IN ERYTHROCYTES; APPROX 65% IS REVERSIBLY BOUND TO PLASMA ALBUMIN. LOW CONCN OF PROTEIN...LOW DEGREE OF BINDING...DRUG EFFICACY.
Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1070
SIGNIFICANT AMT APPEAR IN LIVER, BILE, KIDNEY, SEMEN, LYMPH, & INTESTINE. ... PENICILLIN DOES NOT READILY ENTER CSF WHEN MENINGES ARE NORMAL.
Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1070
ORAL DOSES OF 500 MG POTASSIUM PENICILLIN G TO HUMAN SUBJECTS RESULT IN URINARY CONCN OF 600 UG/ML, FOR 2 HR, & 300 UG/ML, FOR 4 HR AFTER DOSING. ... INEFFICIENT PLACENTAL TRANSFER IS CONSISTENT WITH LOW LIPID SOLUBILITY & LOW IONIZATION CONSTANT OF PENICILLIN G & THERE IS NO EVIDENCE OF PLACENTAL TRANSPORT.
The Chemical Society. Foreign Compound Metabolism in Mammals Volume 3. London: The Chemical Society, 1975., p. 167
...RAPIDLY ELIMINATED FROM BODY, MAINLY BY KIDNEY BUT IN SMALL PART IN BILE & BY OTHER CHANNELS. ... CLEARANCE VALUES ARE CONSIDERABLY LOWER IN NEONATES & INFANTS, BECAUSE OF INCOMPLETE DEVELOPMENT OF RENAL FUNCTION...
Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1071
For more Absorption, Distribution and Excretion (Complete) data for PENICILLIN G (21 total), please visit the HSDB record page.
About 16-30% of an intramuscular dose is metabolized to penicilloic acid, an inactive metabolite. Small amounts of 6-aminopenicillanic acid have been recovered in the urine of patients on penicillin G. A small percentage of the drug appears to be hydroxylated into one or more active metabolites, which are also excreted via urine.
Approx 16-30% of an IM dose of penicillin G sodium is metabolized to penicilloic acid which is microbiologically inactive. Small amt of 6-aminopenicillanic acid (6-APA) have also been found in the urine of patients receiving penicillin G. In addition, the drug appears to be hydroxylated to a small extent to one or more microbiologically active metabolites which are also excreted in urine.
McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 95. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1995 (Plus Supplements 1995)., p. 249
In adults with normal renal function is reportedly 0.40.9 hours
ELIMINATION HALF-LIFE IS ABOUT 30 MIN IN NORMAL ADULTS.
Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1071
PENICILLIN HALF-LIFE IN HUMAN SERUM INCR FROM ABOUT 25 MIN IN YOUNG ADULTS TO 2 HR IN ELDERLY SUBJECTS & IS ALSO MARKEDLY INCR BY DRUGS WHICH ARE ACTIVELY SECRETED BY KIDNEY TUBULES. /PENICILLIN/
The Chemical Society. Foreign Compound Metabolism in Mammals Volume 3. London: The Chemical Society, 1975., p. 167
The serum half-life of penicillin G in adults with normal renal function is reportedly 0.4-0.9 hr.
McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 95. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1995 (Plus Supplements 1995)., p. 249
The serum half-life of penicillin G in neonates varies inversely with age and appears to be independent of birthweight. The serum half-life of the drug is reportedly 3.2-3.4 hr in neonates 6 days of age or younger, 1.2-2.2 hr in neonates 7-13 days of age, and 0.9-1.9 hr in neonates 14 days of age or older.
McEvoy, G.K. (ed.). American Hospital Formulary Service - Drug Information 95. Bethesda, MD: American Society of Hospital Pharmacists, Inc., 1995 (Plus Supplements 1995)., p. 249
By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, penicillin G inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that penicillin G interferes with an autolysin inhibitor.
The penicillins and their metabolites are potent immunogens because of their ability to combine with proteins and act as haptens for acute antibody-mediated reactions. The most frequent (about 95 percent) or "major" determinant of penicillin allergy is the penicilloyl determinant produced by opening the beta-lactam ring of the penicillin. This allows linkage of the penicillin to protein at the amide group. "Minor" determinants (less frequent) are the other metabolites formed, including native penicillin and penicilloic acids. /Penicillins/
Haddad, L.M., Clinical Management of Poisoning and Drug Overdose. 2nd ed. Philadelphia, PA: W.B. Saunders Co., 1990., p. 953
Bactericidal; inhibit bacterial cell wall synthesis. Action is dependent on the ability of penicillins to reach and bind penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall. Penicillin-binding proteins (which include transpeptidases, carboxypeptidases, and endopeptidases) are enzymes that are involved in the terminal stages of assembling the bacterial cell wall and in reshaping the cell wall during growth and division. Penicillins bind to, and inactivate, penicillin-binding proteins, resulting in the weakening of the bacterial cell wall and lysis. /Penicillins/
USP Convention. USPDI - Drug Information for the Health Care Professional. 15 th ed. Volume 1. Rockville, MD: United States Pharmacopeial Convention, Inc., 1995. (Plus updates.), p. 2150
API SUPPLIERS
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5
Submission : 1940-01-01
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
VMF Number : 5317
Submission : 1990-07-06
Status : Inactive
Type : II
Registration Number : 226MF10047
Registrant's Address : Industry Zone, Tuoketuo, Hohhot, Inner Mongolia, China
Initial Date of Registration : 2014-02-20
Latest Date of Registration :
NDC Package Code : 58775-001
Start Marketing Date : 1988-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
92
PharmaCompass offers a list of Benzyl Penicillin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Benzyl Penicillin manufacturer or Benzyl Penicillin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Benzyl Penicillin manufacturer or Benzyl Penicillin supplier.
PharmaCompass also assists you with knowing the Benzyl Penicillin API Price utilized in the formulation of products. Benzyl Penicillin API Price is not always fixed or binding as the Benzyl Penicillin Price is obtained through a variety of data sources. The Benzyl Penicillin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Bencilpenicilina [Spanish] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bencilpenicilina [Spanish], including repackagers and relabelers. The FDA regulates Bencilpenicilina [Spanish] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bencilpenicilina [Spanish] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bencilpenicilina [Spanish] manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bencilpenicilina [Spanish] supplier is an individual or a company that provides Bencilpenicilina [Spanish] active pharmaceutical ingredient (API) or Bencilpenicilina [Spanish] finished formulations upon request. The Bencilpenicilina [Spanish] suppliers may include Bencilpenicilina [Spanish] API manufacturers, exporters, distributors and traders.
click here to find a list of Bencilpenicilina [Spanish] suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Bencilpenicilina [Spanish] DMF (Drug Master File) is a document detailing the whole manufacturing process of Bencilpenicilina [Spanish] active pharmaceutical ingredient (API) in detail. Different forms of Bencilpenicilina [Spanish] DMFs exist exist since differing nations have different regulations, such as Bencilpenicilina [Spanish] USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Bencilpenicilina [Spanish] DMF submitted to regulatory agencies in the US is known as a USDMF. Bencilpenicilina [Spanish] USDMF includes data on Bencilpenicilina [Spanish]'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Bencilpenicilina [Spanish] USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Bencilpenicilina [Spanish] suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Bencilpenicilina [Spanish] Drug Master File in Japan (Bencilpenicilina [Spanish] JDMF) empowers Bencilpenicilina [Spanish] API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Bencilpenicilina [Spanish] JDMF during the approval evaluation for pharmaceutical products. At the time of Bencilpenicilina [Spanish] JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Bencilpenicilina [Spanish] suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bencilpenicilina [Spanish] as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bencilpenicilina [Spanish] API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bencilpenicilina [Spanish] as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bencilpenicilina [Spanish] and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bencilpenicilina [Spanish] NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bencilpenicilina [Spanish] suppliers with NDC on PharmaCompass.
Bencilpenicilina [Spanish] Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bencilpenicilina [Spanish] GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bencilpenicilina [Spanish] GMP manufacturer or Bencilpenicilina [Spanish] GMP API supplier for your needs.
A Bencilpenicilina [Spanish] CoA (Certificate of Analysis) is a formal document that attests to Bencilpenicilina [Spanish]'s compliance with Bencilpenicilina [Spanish] specifications and serves as a tool for batch-level quality control.
Bencilpenicilina [Spanish] CoA mostly includes findings from lab analyses of a specific batch. For each Bencilpenicilina [Spanish] CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bencilpenicilina [Spanish] may be tested according to a variety of international standards, such as European Pharmacopoeia (Bencilpenicilina [Spanish] EP), Bencilpenicilina [Spanish] JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bencilpenicilina [Spanish] USP).
